公开(公告)号：EP1844026B1

公开(公告)日：2011-04-27

申请号：EP06700277.4

申请日：2006-01-10

申请人： F.Hoffmann-La Roche AG ,  VERNALIS RESEARCH LIMITED

发明人： BENTLEY, Jonathan, Mark ,  DAWSON, Claire, Elizabeth ,  GUBA, Wolfgang ,  HEBEISEN, Paul ,  MONCK, Nathaniel ,  PRATT, Robert, Mark ,  RICHTER, Hans ,  ROEVER, Stephan ,  RUSTON, Vicki

IPC分类号： C07D265/30 ,  A61K31/5375 ,  A61P3/04 ,  A61P3/10

CPC分类号： C07D265/30

摘要： The present invention refers to chemical compounds of formula (I) as well as pharmaceutically acceptable salts and esters thereof, wherein R1 to R5 have the significance given in claim 1. These compounds can be used for the preparation of medicaments.

公开(公告)号：EP1844026A2

公开(公告)日：2007-10-17

申请号：EP06700277.4

申请日：2006-01-10

申请人： F.HOFFMANN-LA ROCHE AG ,  VERNALIS RESEARCH LIMITED

发明人： BENTLEY, Jonathan, Mark ,  DAWSON, Claire, Elizabeth ,  GUBA, Wolfgang ,  HEBEISEN, Paul ,  MONCK, Nathaniel ,  PRATT, Robert, Mark ,  RICHTER, Hans ,  ROEVER, Stephan ,  RUSTON, Vicki

IPC分类号： C07D265/30 ,  A61K31/5375 ,  A61P3/04 ,  A61P3/10

CPC分类号： C07D265/30

摘要： The present invention refers to chemical compounds of formula (I) as well as pharmaceutically acceptable salts and esters thereof, wherein R1 to R5 have the significance given in claim 1. These compounds can be used for the preparation of medicaments.